Literature DB >> 23861342

Subthalamus deep brain stimulation for primary dystonia patients: a long-term follow-up study.

Chunyan Cao1, Yixin Pan, Dianyou Li, Shikun Zhan, Jing Zhang, Bomin Sun.   

Abstract

BACKGROUND: Deep brain stimulation has generated sustained improvement in motor function for patients with dystonia, but the long-term impact of subthalamic nucleus stimulation on dystonia has not been elucidated.
METHODS: Patients with primary dystonia underwent bilateral subthalamic nucleus stimulation and were evaluated with the Burke-Fahn-Marsden dystonia rating scale and the Medical Outcomes Study 36-item Short-Form General Health Survey at baseline and 1 month, 1 year, and 3 to 10 years postoperatively.
RESULTS: Improvements in motor function according to the Burke-Fahn-Marsden dystonia rating scale at 1 month, 1 year, and 3 to 10 years of stimulation were 55%, 77%, and 79%, respectively. The quality of life improved after 1 month of stimulation (P < 0.001), progressed within 1 year (P < 0.001), and then remained stable. Disease duration was negatively correlated with an improvement in motor function.
CONCLUSIONS: Our results demonstrate that the subthalamus is an alternative to the globus pallidus internus as a target for deep brain stimulation to treat primary dystonia.
© 2013 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Burke-Fahn-Marsden dystonia rating scale; Medical Outcomes Study 36-item Short-Form General Health Survey; deep brain stimulation; primary dystonia; subthalamic nucleus

Mesh:

Year:  2013        PMID: 23861342     DOI: 10.1002/mds.25586

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

Review 1.  Treatment of dystonia.

Authors:  Mary Ann Thenganatt; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 2.  Arching deep brain stimulation in dystonia types.

Authors:  Han-Joon Kim; Beomseok Jeon
Journal:  J Neural Transm (Vienna)       Date:  2021-03-19       Impact factor: 3.575

Review 3.  Deep brain stimulation for movement disorders: update on recent discoveries and outlook on future developments.

Authors:  Philipp Mahlknecht; Patricia Limousin; Thomas Foltynie
Journal:  J Neurol       Date:  2015-06-03       Impact factor: 4.849

Review 4.  Surgery for Dystonia and Tremor.

Authors:  Jason L Crowell; Binit B Shah
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

5.  Quality of life outcomes after deep brain stimulation in dystonia: A systematic review.

Authors:  Takashi Tsuboi; Joshua K Wong; Michael S Okun; Adolfo Ramirez-Zamora
Journal:  Parkinsonism Relat Disord       Date:  2019-11-18       Impact factor: 4.402

Review 6.  PET Neuroimaging: Insights on Dystonia and Tourette Syndrome and Potential Applications.

Authors:  Pierpaolo Alongi; Leonardo Iaccarino; Daniela Perani
Journal:  Front Neurol       Date:  2014-09-23       Impact factor: 4.003

7.  Long-term Effects of Subthalamic Nucleus Deep Brain Stimulation in Tardive Dystonia.

Authors:  Da-Wei Meng; Huan-Guang Liu; An-Chao Yang; Kai Zhang; Jian-Guo Zhang
Journal:  Chin Med J (Engl)       Date:  2016-05-20       Impact factor: 2.628

8.  The safety issues and hardware-related complications of deep brain stimulation therapy: a single-center retrospective analysis of 478 patients with Parkinson's disease.

Authors:  Jing Zhang; Tao Wang; Chen-Cheng Zhang; Kristina Zeljic; Shikun Zhan; Bo-Min Sun; Dian-You Li
Journal:  Clin Interv Aging       Date:  2017-06-08       Impact factor: 4.458

Review 9.  Recent advances in understanding and managing dystonia.

Authors:  Stephen Tisch
Journal:  F1000Res       Date:  2018-07-24

10.  Cortico-subthalamic Coherence in a Patient With Dystonia Induced by Chorea-Acanthocytosis: A Case Report.

Authors:  Chunyan Cao; Peng Huang; Tao Wang; Shikun Zhan; Wei Liu; Yixin Pan; Yiwen Wu; Hongxia Li; Bomin Sun; Dianyou Li; Vladimir Litvak
Journal:  Front Hum Neurosci       Date:  2019-05-28       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.